Philip Morris International Inc. filings document the reporting obligations of a global tobacco and smoke-free products company with NYSE-listed common stock and multiple listed note series. The record includes Form 8-K material-event reports, periodic-report references, proxy materials, and exchange notices covering debt securities.
The company’s disclosures address operating results, risk factors, product and regulatory matters, capital structure, debt listings, shareholder voting, director elections, executive compensation, auditor ratification, shareholder proposals, and notices of removal from listing or registration for specified notes.
Philip Morris International Inc. reported nine-month net revenues of $32.776 billion, compared with $30.286 billion in 2025, and operating income of $13.289 billion, compared with $11.519 billion. Net earnings attributable to PMI were $8.568 billion versus $9.207 billion, and diluted earnings per share were $5.48 versus $5.89. Third-quarter net revenues were $11.438 billion versus $10.845 billion, while net earnings attributable to PMI were $3.313 billion versus $3.478 billion.
Nine-month operating cash flow was $10.445 billion, compared with $7.524 billion. Net revenues by reportable segment for the nine months were $11.580 billion for International Smoke-Free, $18.872 billion for International Combustibles, and $2.324 billion for the U.S. The income statement includes a $511 million impairment related to the RBH equity investment and a $330 million net loss on equity investments and securities, compared with $926 million of net income in that line in 2025. At September 30, 2026, cash and cash equivalents were $6.683 billion and long-term debt was $41.709 billion.
Philip Morris International Inc. reported third-quarter 2026 net revenue of $11.4 billion, up 5.5% year over year, and operating income increased 14.1%. Adjusted diluted EPS rose 5.4% to $2.36, while reported diluted EPS fell 4.9% to $2.12, mainly reflecting a non-cash fair-value adjustment for equity-security investments. Smoke-free products accounted for more than 40% of quarterly net revenue; their shipments increased 2.7%, and PMI smoke-free products were available in 110 markets.
For 2026, PMI projects organic net-revenue growth of 5% to 7% and organic operating-income growth of 7% to 9%. Adjusted diluted EPS growth is projected at 9.9% to 11.9% versus 2025 adjusted diluted EPS of $7.54, or 7.5% to 9.5% excluding currency. The company increased its regular quarterly dividend 8.8% to $1.60 per share. U.S. year-to-date net revenue and gross profit declined 5.2% and 14.8%, respectively. PMI said energy-related inflation added third-quarter cost pressure and Ukraine-related supply-chain and logistics disruptions are expected to affect operating income this year.
Philip Morris International Inc. (PM) announced that its Board of Directors increased the regular quarterly dividend to $1.60 per common share, up from $1.47, equivalent to an annualized rate of $6.40 per share. The dividend is payable on October 26, 2026 to shareholders of record as of October 2, 2026, with the ex-dividend date also on October 2, 2026.
The company states it has raised its annual dividend every year since 2008, a total increase of 248%, representing a compound annual growth rate of 7.2%. Philip Morris International also highlights the growth of its smoke-free portfolio, noting that smoke-free products accounted for approximately 42% of second-quarter 2026 net revenues and were used by over 43 million legal-age consumers as of December 31, 2025.
Philip Morris International Inc. (PM) provides updated guidance and strategic commentary in connection with a presentation by CEO Jacek Olczak at the Barclays Global Consumer Conference. PMI now targets 2026 adjusted diluted EPS of $8.35–$8.50, compared with $7.54 in 2025, implying 10.7%–12.7% growth, including a $0.24 favorable currency impact. Adjusted diluted EPS excluding currency is forecast at $8.11–$8.26, or 7.5%–9.5% growth. For the third quarter of 2026, PMI forecasts adjusted diluted EPS of $2.29–$2.34, including a $0.01 currency benefit. The company highlights continued growth of smoke-free products led by IQOS, expansion of the ZYN portfolio in the U.S., and ongoing robust performance of combustibles, while also reiterating detailed forward-looking risk factors affecting regulation, taxation, litigation, competition, Geopolitics, and execution of its smoke-free strategy.
Philip Morris International Inc. (PM) updated its 2026 outlook alongside a presentation by Group CEO Jacek Olczak at the Barclays Global Consumer Conference. The company now forecasts 2026 reported diluted EPS of $7.28–$7.43, reflecting currency effects only.
Excluding a total 2026 adjustment of $1.07 per share, PMI expects adjusted diluted EPS of $8.35–$8.50, a projected increase of 10.7%–12.7% versus $7.54 in 2025. Excluding a favorable currency impact of $0.24 per share, the adjusted diluted EPS forecast of $8.11–$8.26 implies growth of 7.5%–9.5%. PMI also updated its Q3 2026 adjusted diluted EPS forecast to $2.29–$2.34, now including an estimated $0.01 favorable currency impact.
The company highlights that smoke-free products represented about 42% of total net revenues in second-quarter 2026 and were used by over 43 million legal-age consumers as of December 31, 2025. PMI has invested more than $16 billion since 2008 to develop and commercialize smoke-free products and notes multiple FDA marketing and Modified Risk Tobacco Product authorizations for parts of its portfolio.
Philip Morris International Inc. (PM) announced that, through its non‑U.S. affiliates, it has entered into a contract manufacturing arrangement for combustible cigarettes with Philip Morris USA, an operating company of Altria Group Inc. The collaboration is intended to leverage the combustible cigarette manufacturing capabilities and expertise of both organizations while PMI continues to focus on a smoke‑free future.
The first shipments under this arrangement are expected to begin early in 2027, subject to operational readiness and applicable regulatory requirements. PMI stated that it does not expect a material impact on its 2026 financials from this arrangement. PMI has not commercialized combustible cigarettes in the United States and has no plans to do so, and this arrangement does not change that position. PMI and Altria will continue to operate independently and remain responsible for their own commercialization, distribution, and regulatory activities.
PMI also highlighted its broader transformation: as of December 31, 2025, smoke‑free products were available in over 105 markets and were used by over 43 million legal‑age consumers, with smoke‑free products accounting for approximately 42% of second‑quarter 2026 total net revenues.
Philip Morris International Inc. executive Massimo Andolina, Group Chief Financial Officer, reported initial beneficial ownership of 71,588 shares of the company’s common stock. This direct holding includes 23,310 Restricted Share Units (RSUs) granted under the Philip Morris International Inc. 2022 Performance Incentive Plan.
Of these RSUs, 7,620 are scheduled to vest on February 17, 2027, 6,850 on February 16, 2028, and 8,840 on February 21, 2029, providing a staged equity-based compensation profile over several years.
Philip Morris International Inc. is removing its 0.125% Notes due 2026 from listing and/or registration on the New York Stock Exchange LLC under Section 12(b) of the Securities Exchange Act of 1934. The exchange states it has complied with its rules to strike this class of securities, and the issuer has complied with the exchange’s rules and the requirements governing the voluntary withdrawal of this class from listing and registration.
Philip Morris International reported strong underlying results for the quarter and six months ended June 30, 2026. Second-quarter net revenues rose to $11.2 billion, up 10.4% (7.6% organically), with shipment volumes up 2.5%, including 7.5% growth in smoke-free products and 1.1% growth in cigarettes. Gross profit increased 11.5% to $7.7 billion, and operating income grew 22.0% to $4.5 billion, expanding the adjusted operating margin to 42.6%.
Reported diluted EPS declined 7.7% to $1.80, primarily due to a $511 million non-cash impairment of the RBH equity investment, while adjusted diluted EPS rose 15.2% to $2.20 (13.6% excluding currency). Smoke-free products generated about 42% of net revenues, with double-digit growth in the International Smoke-Free segment; the U.S. segment saw a 0.7% net revenue decline in the quarter and a 16.1% decline year-to-date despite modest ZYN shipment growth.
For the first half of 2026, net revenues reached $21.3 billion, up 9.8%, and adjusted diluted EPS increased to $4.16 from $3.60. Operating cash flow for the first six months was $5.1 billion, up 66.3%. Management forecasts 2026 adjusted diluted EPS of $8.26–$8.41, implying 9.5%–11.5% growth versus 2025, or 7.5%–9.5% excluding currency, based on 5%–7% organic net revenue growth and 7%–9% organic operating income growth.